mesgro

About Melissa Esgro

This author has not yet filled in any details.
So far Melissa Esgro has created 6 blog entries.

TrialCard Announces Enhancements to Pharmacy Fraud Detection Solution

MORRISVILLE, NC—Pharmaceutical solutions provider, TrialCard Incorporated, today announced improvements to its pharmacy fraud detection and mitigation solution.  These improvements include the development and use of its proprietary tool, “Spotlight,” to discover potentially fraudulent pharmacy claims activity on a near real-time basis. This early detection tool enables TrialCard to identify and block pharmacies that are routinely submitting fraudulent co-pay claims before payment is made to the pharmacy in question. “Our analytics professionals and fraud investigators have worked diligently to develop this enhancement,” said Matt Turner, TrialCard’s Director of Product Management for Risk and Compliance Solutions. “By deploying improvements to our [...]

2018-12-11T13:34:57+00:00December 11th, 2018|

TrialCard Introduces New Non-Commercial Dispensing Pharmacy

MORRISVILLE, NC—TrialCard Incorporated, a leader in patient and provider access, adherence, and engagement solutions, today formally introduced TC Script, its new non-commercial dispensing pharmacy. The addition of TC Script will allow TrialCard to administer traditional patient assistance programs (PAPs) on behalf of pharmaceutical manufacturers. "The introduction of TC Script enables us to once more expand our service offerings to our pharmaceutical clientele," said Mark Bouck, President and CEO of TrialCard. "Assisting indigent patients with access to therapy is extremely important to TrialCard and is a vital component of a successful brand strategy for many pharmaceutical products." TC Script's capabilities [...]

2018-10-15T01:12:14+00:00October 15th, 2018|

TrialCard Announces Partnership With EvinceMed

MORRISVILLE, NC—Pharmaceutical services provider TrialCard Incorporated announced today that it has entered into a formal partnership with EvinceMed Corporation, a company that streamlines and automates the specialty medication prescription process for providers, specialty pharmacies, hubs, PBMs, and health plans. “This partnership allows both TrialCard and EvinceMed to showcase each company’s strengths to deliver medicine to the patient as quickly and easily as possible,” said David Jackson, CEO of EvinceMed. “EvinceMed’s proprietary technology and data networks significantly reduce the time, cost, and burden associated with the approval of specialty medications that treat complex and chronic conditions.” “The pharmaceutical patient support [...]

2018-09-10T09:55:53+00:00September 10th, 2018|

Defining Digital Health

Digital health. It's all the rage. What is it? More importantly, what does it mean to companies like ours that have been building longstanding pharmaceutical partners and successfully interacting with patients, pharmacists, and providers for more than 15 years? TrialCard has invested substantially in attempting to answer this question in two ways. It has attended most, if not all, Digital Health conferences on the East and West coasts. It built QuickPath™, a technology platform that has the ability to scale with future affordability, adherence, and engagement needs of its pharmaceutical partners and their patients. Boldly, I believe TrialCard has an [...]

2018-09-07T14:43:51+00:00September 7th, 2018|

Life as an Intern at TrialCard

When I graduated from college in May, I experienced a mix of emotions. I was proud of myself for everything I had accomplished during my four years at Clemson. I worked in the Social Media Listening Center—a research lab and teaching facility where students could track real-time chatter of events such as presidential elections, sporting events, and other news items. This experience piqued my interest in social media analytics. I also had the opportunity to study abroad in Germany and advance my communication skills and knowledge in public relations. And in my last year of college, I completed my [...]

2018-08-06T10:01:52+00:00July 20th, 2018|

Asembia 2018: Hot Topics and Key Industry Trends

Another Asembia is in the rearview mirror and once again I’m amazed at how many key learnings come out of attending this annual trade show. Since last year’s event, there have been numerous industry developments that have dominated the headlines. From the announced mega-mergers of ESI / Cigna and CVS / Aetna to the almost daily chatter about Amazon “disrupting the drug channel” there is a reason for both anxiety and optimism within the specialty drug community. All of these shifting marketplace dynamics created the perfect environment for some collaborative discussions during the course of the conference. Read on to learn about some of the hottest topics and [...]

2018-08-29T11:34:01+00:00May 29th, 2018|